25Serious

Barry Zito

Barry Zito

Ask VT AI

View News Summary

Dramatic collision at Poland level crossing as van gets trapped, driver unharmed
Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Latest News

Barry Zito, Baseball

Orioles, Nationals Struggle in MLB AL, NL East Standings

100% left coverage2 sources

Barry Zito, Baseball

Orioles, Nationals Struggle in MLB AL, NL East Standings

100% left coverage2 sources

Orioles, Nationals Struggle in MLB AL, NL East Standings

Orioles, Nationals Struggle in MLB AL, NL East Standings

Barry Zito, MLB

Oakland A's Prepare for Move to Las Vegas

50% left coverage2 sources

Barry Zito, MLB

Oakland A's Prepare for Move to Las Vegas

50% left coverage2 sources

Oakland A's Prepare for Move to Las Vegas

Oakland A's Prepare for Move to Las Vegas

Oakland A's final game

100% left coverage3 sources

Oakland A's final game

100% left coverage3 sources

Oakland A's final game

Oakland A's final game

Oakland A's final game

50% left coverage2 sources

Oakland A's final game

50% left coverage2 sources

Oakland A's final game

Oakland A's final game

Oakland Athletics Lead Giants in Series

100% left coverage1 source

Oakland Athletics Lead Giants in Series

100% left coverage1 source

Oakland Athletics Lead Giants in Series

Oakland Athletics Lead Giants in Series

Chris Sale Shines in Braves' Loss to White Sox

100% center coverage1 source

Chris Sale Shines in Braves' Loss to White Sox

100% center coverage1 source

Chris Sale Shines in Braves' Loss to White Sox

Chris Sale Shines in Braves' Loss to White Sox

Ask VT AI

View News Summary

Dramatic collision at Poland level crossing as van gets trapped, driver unharmed
Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Barry Zito